One milion and counting

Reproductive BioMedicine Online

Volumn 13, Issue 3, 2006, Pages 313-314

  Gordon, Keith ^a   Prins, Marjanne ^b   Schuller, Klaus ^a   Lewin, Joy ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NV ORGANON   (Netherlands)

Author keywords

Follitropin beta; Ovarian stimulation; Ovulation induction; Recombinant FSH

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; RECOMBINANT FOLLITROPIN; FOLLITROPIN BETA SUBUNIT;

ANOVULATION; ARTICLE; CALCULATION; DELIVERY; DRUG MANUFACTURE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MALE INFERTILITY; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY RATE; PROGNOSIS; REGISTER; TREATMENT OUTCOME; DRUG EFFECT; METHODOLOGY; OVARY; STATISTICS;

FEMALE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; HUMANS; OVARY; OVULATION INDUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 33748584625     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61432-0     Document Type: Note

References (13)

1. Andersen AN, Gianaroli L, Felberbaum R et al. 2005 Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Human Reproduction 20, 1158-1176.
2. Arslan M, Bocca S, Mirkin S et al. 2005 Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertility and Sterility 84, 555-569.
3. Centers for Disease Control and Prevention 2005 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta, Georgia: Centers for Disease Control and Prevention.
4. Checa MA, Prat M, Robles A, Carreras R 2006 Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertility and Sterility 85, 573-577.
5. Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z 2005 Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertility and Sterility 84, 1023-1026.
6. Garcia JE, Kettel LM, Klein NA et al. 2004 An aqueous formulation of recombinant human FSH is more efficient than a freeze-dried cake formulation in clomiphene-resistant women with chronic anovulation. Today's Therapeutic Trends 22, 147-165.
7. Kettel LM, Scholl G, Bonaventura L et al. 2004 Evaluation of a pen device for self-administration of recombinant human follicle-stimulating hormone in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Reproductive BioMedicine Online 9, 373-380.
8. Kolibianakis EM, Schultze-Mosgau A, Schroer A et al. 2005 A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Human Reproduction 20, 2887-2892.
9. Lambalk CB, Leader A, Olivennes F et al. 2006 Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Human Reproduction 21, 632-639.
10. Messinis IE 2005 Ovulation induction: a mini review. Human Reproduction 20, 2688-2697.
11. Platteau P, Andersen AN, Balen A et al. JC 2006 Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Human Reproduction 21, 1798-1804.
12. Ragni G, Caliari I, Nicolosi AE et al. 2006 Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and Sterility 85, 619-624.
13. Sedbon E, Wainer R, Perves C 2006 Quality of life of patients undergoing ovarian stimulation with injectable drugs in relation to medical practice in France. Reproductive BioMedicine Online 12, 298-303.